Biography:
Pedro Plans-Rubió is Responsible for Health Registries, Public Health Agency of Catalonia, Health Department of Catalonia, Spain. He received his MD from the School of Medicine, University of Barcelona; his PhD from the School of Medicine, University of Barcelona, his MSc in Health Economics from the School of Economics, University of Barcelona, and his MSc in Design of clinical and epidemiological studies from the School of Medicine, University of Barcelona. Specialist in Preventive Medicine and Public Health. Specialist in Labor Medicine. Member of the research group CIBER of Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. Member of the research group “Pertussis transmission in Catalonia and Navarra”. Member of the research group “Global Burden of Metabolic Risk Factors of Chronic Diseases”. He has published more than 100 articles in scientific journals on the epidemiology of infectious diseases, epidemiology of risk factors for chronic diseases and for infectious diseases, seroepidemiology, cost-effectiveness analysis of medicines and health programs, vaccination programs, and health policy. He has published more than 100 articles in scientific journals. He has published the book “Application of the cost-effectiveness of medicines and health programs in the health planning”, Elsevier, 2015. Editor-in Chief of Section “Vaccine Efficacy and Safety” of the journal Vaccines and Editor of several Special Issues of the journal Vaccines. Member of the Editorial Board of the journals Pharmacoeconomics Open.
Title : Adapted mRNA COVID-19 vaccines have a limited ability to establish herd immunity in the population against Omicron BA.1 and BA4-5 variants of SARS-CoV-2